Validation of the PREsTo machine learning algorithm for the prediction of disease progression in patients with PSC

Apr 8, 2019 | Ethan McConkey, Moderator | @ethanmcconkey

2019-04-12 AI

In an abstract presented this week at the 2019 European Association for the Study of the Liver (EASL) meeting in Vienna, Austria, Dr. John Eaton from Mayo Clinic, Rochester, MN, reported the confirmation of the PREsTo machine learning algorithm for the prognostication of disease progression in a randomized trial of PSC patients.

The PDF of the published article can be found here.

Join others discussing PSC

Please sign in or register to post a reply.